(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)
Philips Respironics has recalled certain BiPAP ventilators due to false alarm issues potentially causing shutdowns. Affected models include BiPAP A30, A40, and V30, along with Omnilab Advanced Plus ventilators. While no harm was reported with V30 or Omnilab units, Philips received 10 reports of serious injury and seven of patient death linked to A30 and A40 devices between 2011 and 2023, though causation wasn't confirmed.
This recall follows Philips' decision to halt most US sleep and respiratory product sales due to a Department of Justice consent decree. The company faced recalls, notably involving over 15 million sleep apnea devices due to foam breakdown.
The current recall, affecting around 100,000 units, is separate from a previous software issue. Philips advises continued device use per instructions while investigating. Most affected V30s were in the US, while A30 and A40 devices were mainly international. Omnilab Advanced Plus recall, starting April 1, covers US and Canada units.
Copyright © 2024 Institute of Good Manufacturing Practices India ( IGMPI® All Rights Reserved. Trademarks are the property of the owner )